Company profile
Electromedical Technologies, Inc.
OTC: EMED · Healthcare · Medical - Devices
#851 of 1,422 Healthcare companies by revenue63rd-percentile growth
EA Score
——FH —DQ 21GM —SS 24
v0.1 · 25/100 weight · pillars only
↑ growth stability, 3-yr revenue growth · ↓ return on assets, balance-sheet leverage
Methodology →Revenue TTM
$27.5k
Rev growth YoY (TTM)
-66.6%
Net income (FY)
-$2.6M
Employees
6
as of 2026-08-28
Market cap
$373.2k
as of 2026-08-28
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$1.3M$1.3M2023
Net income-$2.6M-$2.6M2023
Operating income-$2.1M-$2.1M2023
Total assets$748.4k$748.4k2023
Liabilities$3.6M$3.6M2023
Equity-$2.9M-$2.9M2023
Revenue trend
FY2020 – FY2023 · USD
FY20
FY20
FY21
FY22
FY23
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Electromedical Technologies, Inc.’s revenue?
Electromedical Technologies, Inc. booked $1.3M in FY2023 revenue, growing 17% year over year — faster than most Healthcare companies we track, at a -195.8% net margin.
Peers · Healthcare
CannaPharmaRX, Inc.38DOneMedNet Corporation26DPanbela Therapeutics, Inc.——Global Roundtable Corporation——Inhibrx Biosciences Inc.28DBhang Inc.——Neighbors
Maricopa →Key facts
CEOMatthew N. Wolfson
SectorHealthcare
IndustryMedical - Devices
HeadquartersScottsdale, AZ
ExchangeOTC: EMED
Employees6
IPO date2021-01-08
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.